Understand the source comparison
Best Peptides for Herpes Simplex: Research Compound Comparison
This table compares the three peptides generating the most HSV-focused research attention based on mechanism, research evidence strength, and practical research application considerations. Thymosin Alpha-1 CD4+ T-cell upregulation, interferon-alpha signalling
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- This table compares the three peptides generating the most HSV-focused research attention based on mechanism, research evidence strength, and practical research application considerations.
- Thymosin Alpha-1
- CD4+ T-cell upregulation, interferon-alpha signalling enhancement
- RCT showing 47% outbreak reduction over 6 months (Clinical Immunology 2021); murine models: 62% viral load reduction
- 1.6 mg subcutaneous 2× weekly for 12 weeks (human); 50–100 mcg in animal models
- Lyophilized storage −20°C; reconstituted 2–8°C, use within 28 days; sensitive to temperature excursions
- Strongest clinical evidence for recurrent HSV; immune modulation rather than direct antiviral action; requires consistent dosing schedule
- LL-37
- Antimicrobial peptide; viral envelope disruption, heparan sulfate binding blockade
- In vitro: 81% HSV-1 plaque reduction, 73% HSV-2 at 10 μg/mL (Antiviral Research 2020); limited human trials
- 5–20 μg/mL topical; 50–100 mcg subcutaneous in research protocols
- Highly susceptible to proteolytic degradation; requires sterile reconstitution with filtered bacteriostatic water
- Direct antiviral activity documented in cell cultures; bioavailability challenges limit systemic use; topical formulations show promise
- Thymulin (Zn-Thymulin)
- Thymic T-cell maturation; CD8+ cytotoxic T-cell production; NK cell activation
- Animal models: 52% ganglia viral load reduction (J Neuroimmunology 2018); minimal human HSV data
- 50–150 mcg subcutaneous 3× weekly (animal equivalent); human dosing under investigation
- Requires zinc coordination for bioactivity; reconstitute with zinc acetate solution (10 mM); standard peptide storage protocols
- Promising mechanism targeting latent HSV in ganglia; limited human data; zinc-binding requirement adds preparation complexity